
Critical Quality Attributes Pertaining to Immunogenicity: A Preponderance of Evidence Approach to Control Strategies

Speaker Presentation Rosenberg Amy CDER, FDA 2018
Critical Quality Attributes Pertaining to Immunogenicity: A Preponderance of Evidence Approach to Control Strategies
Critical Quality Attributes Pertaining to Immunogenicity: A Preponderance of Evidence Approach to Control Strategies